The development of EBIs involves several key steps. Initially, a hypothesis is formed based on preclinical studies and preliminary data. This is followed by a series of clinical trials, typically in three phases:
1. Phase I: Tests the safety and dosage of the intervention. 2. Phase II: Evaluates the efficacy and side effects. 3. Phase III: Confirms the efficacy on a larger scale and compares it to standard treatments.
Once an intervention passes these phases, it may be approved by regulatory bodies such as the FDA and incorporated into clinical practice.
